This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Grines, C. L. Search for Related Content PubMed PubMed Citation Articles by Grines, C. L.

A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction

The air primary angioplasty in myocardial infarction study

Cindy L. Grines, MD, FACC^*,*, Donald R. Westerhausen, Jr, MD, FACC, Lorelei L. Grines, PhD^*, J. Timothy Hanlon, MD, FACC, Timothy L. Logemann, MD, FACC, Matti Niemela, MD^||, W. Douglas Weaver, MD, FACC^¶, Marianne Graham, RN^*, Judith Boura, MS^*, William W. O’Neill, MD, FACC^*, Carlos Balestrini, MD^# Air PAMI Study Group

^* Division of Cardiology, William Beaumont Hospital, Royal Oak, Michigan, USA
Division of Cardiology, St. Joseph Medical Center, South Bend, Indiana, USA
Division of Cardiology, St. Charles Hospital, Bend, Oregon, USA
Division of Cardiology Wausau Hospital, Wausau, Wisconsin, USA
^|| Division of Cardiology, Oulu University Hospital, Oulu, Finland
^¶ Division of Cardiology, Henry Ford Hospital, Detroit, Michigan, USA
^# Division of Cardiology, Instituto Modelo de Cardiologia, Cordoba, Argentina

View larger version (27K): [in a new window]   Figure 1 Thirty-day clinical events were non-significantly improved in the group transferred for primary percutaneous transluminal coronary angioplasty (PTCA). CVA = cerebrovascular accident; MACE = major adverse cardiac events (i.e., combined end point of death, repeat MI and disabling stroke); reMI = non-fatal reinfarction.